
The over-the-counter medicine business is proving to be a lucrative one. And it’s one that is doing well in the current environment of a gradually slowing economy.
Some of the world’s largest pharmaceutical companies - faced with looming patent expirations on some of their best-selling prescription medicines - realized they needed to plow serious money into research and development.